Inactive Instrument
Sector Provectus Biopharmaceuticals Inc NYSE
Stocks
US74373P1084
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-25 | Provectus Biopharmaceuticals, Inc. Launches Veripure Open Science Program For Medical Research Access To PV-10 | CI |
| 06-19 | Provectus Biopharmaceuticals, Inc. - Shareholder/Analyst Call |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.31% | -0.20% | +13.01% | +32.37% | +13.20% | +72.71% | +128.31% | +218.07% | +7,017.54% | 55.78B | |
| -1.32% | +16.55% | +22.55% | +28.36% | +37.37% | +89.14% | +101.41% | -21.18% | - | 55.66B | |
| -0.83% | +3.21% | +2.00% | +9.71% | -1.75% | -12.15% | -13.34% | -58.22% | - | 23.84B | |
| +3.20% | +5.81% | +1.94% | -29.50% | -37.90% | +7.40% | +412.25% | +279.78% | +996.20% | 22.7B | |
| +4.45% | +5.06% | +9.52% | +6.31% | -11.45% | +36.50% | -30.43% | -30.05% | +48.35% | 16.12B | |
| +0.64% | +6.36% | +8.60% | +30.17% | +24.58% | +23.89% | +185.74% | +199.70% | +599.17% | 13.64B | |
| +5.51% | +22.37% | +44.09% | +109.38% | +185.11% | +171.85% | +333.54% | +1,617.14% | +633.62% | 14.8B | |
| +1.36% | +3.76% | +10.71% | +5.43% | -8.51% | +76.04% | +130.63% | +446.93% | - | 12.16B | |
| -1.99% | +6.92% | +16.11% | +35.86% | +34.64% | +158.93% | +162.26% | +332.29% | +801.48% | 11.85B | |
| +2.78% | +3.67% | +10.15% | +43.68% | +24.76% | +424.24% | +132.28% | +0.01% | +1,456.95% | 11.34B | |
| +1.50% | +2.60% | -6.94% | -13.90% | -16.41% | -31.30% | +482.47% | +95.98% | +88.16% | 11.11B | |
| -0.04% | +0.02% | +32.74% | +27.65% | +22.74% | +61.82% | +192.78% | - | - | 9.76B | |
| -0.17% | +20.01% | +21.34% | +31.91% | +343.69% | +232.77% | +216.01% | -38.48% | - | 9.19B | |
| +2.44% | +14.31% | +21.44% | +8.07% | +28.73% | +82.70% | +18.93% | +163.86% | - | 8.33B | |
| -0.07% | -6.50% | +28.64% | +99.78% | +176.98% | +506.15% | +705.68% | -47.85% | -25.32% | 7.83B | |
| +0.73% | -0.66% | -2.41% | +13.02% | +6.19% | +18.03% | +70.73% | +2.64% | +239.07% | 7.11B | |
| -8.22% | +4.24% | -11.16% | -19.02% | -42.13% | - | - | - | - | 7.56B | |
| +0.76% | +8.29% | +17.16% | +28.88% | +26.04% | +56.75% | +636.34% | +92.11% | - | 6.59B | |
| +1.65% | +8.70% | +13.39% | +11.53% | +11.12% | +449.72% | +233.36% | +386.68% | - | 6.62B | |
| Average | +0.80% | +4.85% | +13.31% | +24.19% | +43.00% | +134.73% | +227.72% | +214.08% | +1,185.52% | 16.42B | |
| Weighted average by Cap. | +1.07% | +4.58% | +14.02% | +24.15% | +32.64% | +100.18% | +180.61% | +191.33% | +2,675.13% |
- Stock Market
- Stocks
- PVCT Stock
- Stock
- Sector Provectus Biopharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
